Sobotka Glenn sold (to issuer) 11,793 shares of ASTH
Sobotka Glenn sold (to issuer) 11,793 shares of Astrana Health, Inc. (ASTH) on 2026-08-07.
How this was made
The 30-second read
Why it matters
The newest fact is the reported sale to the issuer of 11,793 shares by Sobotka Glenn, with holdings after transaction of 2,246 shares. No 10b5-1 plan is indicated and no price/value is provided.
Market read
Primarily a compliance disclosure; without disclosed price/value or a broader corporate catalyst, it is unlikely to drive a new trading thesis.
What to watch
Because the price and total value are not disclosed, traders cannot assess whether the sale was at favorable or unfavorable levels, reducing interpretability.
Background
This is an SEC Form 4 insider transaction disclosure for Astrana Health, Inc. (ASTH).
Ticker impact
Astrana Health (ASTH) disclosed an insider sale to the issuer of 11,793 shares by Sobotka Glenn on 2026-08-07 via Form 4.
Low likelihood of a sustained price move based solely on this Form 4.
The filing is a Form 4 insider sale to the issuer (buyback participation style) with price/value not disclosed and no accompanying corporate event or guidance change.
Market effects
No clear sector read-through from a single routine insider sale.
None indicated.
None indicated.
Counterpoint
If the sale is part of a larger, undisclosed pattern of insider de-risking, it could modestly pressure sentiment, but this filing alone provides limited evidence.
Key entities
- issuerAstrana Health, Inc.
Company subject of the Form 4 insider transaction disclosure (ASTH).
- insiderSobotka Glenn
Reporter of the Form 4 transaction, selling 11,793 shares to the issuer.
